This Article Abstract Free Full Text (Free PDF) Free Alert me when this article is cited Alert me if a correction is posted Citation Map Services Email this article to a friend Similar articles in this journal Similar articles in Web of Science Similar articles in PubMed Alert me to new issues of the journal Add to Saved Citations Download to citation manager Request Permissions Request Reprints Add to My Marked Citations Citing Articles Citing Articles via HighWire Citing Articles via Web of Science (11) Citing Articles via Google Scholar Citing Articles via Scopus Google Scholar Articles by Marketou, M. E. Articles by Vardas, P. E. Search for Related Content PubMed PubMed Citation Articles by Marketou, M. E. Articles by Vardas, P. E. Social Bookmarking                         What's this?

Early Effects of Simvastatin versus Atorvastatin on Oxidative Stress and Proinflammatory Cytokines in Hyperlipidemic Subjects

Department of Cardiology, Heraklion University Hospital, Heraklion, Crete, Greece

Evangelos A. Zacharis, MD

Department of Cardiology, Heraklion University Hospital, Heraklion, Crete, Greece

Dragana Nikitovic

Department of Cardiology, Heraklion University Hospital, Heraklion, Crete, Greece

Emmanuel S. Ganotakis, MD

Department of Internal Medicine, Heraklion University Hospital, Heraklion, Crete, Greece

Frangiskos I. Parthenakis, MD

Department of Cardiology, Heraklion University Hospital, Heraklion, Crete, Greece

Niki Maliaraki, MD

Department of Laboratory of Biochemistry, Heraklion University Hospital, Heraklion, Crete, Greece

Panos E. Vardas, MD, PhD

Department of Cardiology, Heraklion University Hospital, Heraklion, Crete, Greece, cardio{at}med.uoc.gr

The authors investigated the time-dependent action of atorvastatin and simvastatin on oxidative stress and cytokine levels immediately after the start of treatment. These factors play a role in endothelial dysfunction. Hyperlipidemic patients (n=132) were assigned to treatment with 40 mg atorvastatin, 40 mg simvastatin, or placebo. Blood samples were taken before, 2 hours, 24 hours, 7 days, and 3 weeks after the administration of the statin or placebo to evaluate serum concentrations of total peroxides (TP), interleukin-6 (IL-6), tumor necrosis factor-alpha (TNF-a) and soluble intercellular vascular adhesion molecule 1 (sICAM 1). In the atorvastatin group the TP changes were significantly different at 2 hours and 24 hours (p=0.005), whereas in the simvastatin group there was a gradual, more or less linear decline in TP until 7 days (p=0.006) and then a plateau. Simvastatin exhibited a faster statistically significant decrease over time in IL-6 and sICAM 1 levels (at 7 days, p=0.014 and p=0.001, respectively). TNF-a demonstrated a faster linear trend in the simvastatin group, but the significant effect appeared late (p=0.006). Both simvastatin and atorvastatin exerted early beneficial effects on oxidative stress, proinflammatory cytokines, and endothelial activation in hyperlipidemic subjects. These effects became significant 2 hours following the initiation of therapy.

References

• Hansson GK: Immune mechanisms in atherosclerosis. Arterioscler Thromb Vasc Biol 21:1876-1890, 2001.[Abstract/Free Full Text]
• Ridker PM, Hennekens CH, Roitman-Johnson B, et al: Plasma concentration of soluble intercellular adhesion molecule-1 and risks of future myocardial infarction in apparently healthy men. Lancet 351:88-92, 1998.[CrossRef][Web of Science][Medline] [Order article via Infotrieve]
• Ridker PM, Rifai N, Pfeffer M, et al: Elevation of tumor necrosis factor-alpha and increased risk of recurrent coronary events after myocardial infarction. Circulation 101:2149-2153, 2000.[Abstract/Free Full Text]
• Case CC, Ballantyne CM: Statins and inflammatory markers. Curr Atheroscler Rep 4:42-47, 2002.[Medline] [Order article via Infotrieve]
• Ascer E, Bertolami MC, Venturinelli ML, et al: Atorvastatin reduces proinflammatory markers in hypercholesterolemic patients. Atherosclerosis 177:161-166, 2004.[CrossRef][Web of Science][Medline] [Order article via Infotrieve]
• Rezaie-Majd A, Maca T, Bucek R, et al: Simvastatin reduces expression of cytokines interleukin-6, interleukin-8, and monocyte chemoattractant protein-1 in circulating monocytes from hypercholesterolemic patients. Arterioscler Thromb Vasc Biol 22:1194-1199, 2002.[Abstract/Free Full Text]
• Schartz GG, Olsson AG, Ezekowitz MD, et al: Effects of atorvastatin on early recurrent ischemic events in acute coronary syndromes. The MIRACL study: A randomized controlled trial. JAMA 285:1711-1718, 2001.[Abstract/Free Full Text]
• Tsiara S, Elisaf M, Mikhailidis DP: Early vascular benefits of statin therapy. Curr Med Res Opin 19:540-556, 2003.[CrossRef][Web of Science][Medline] [Order article via Infotrieve]
• Laufs U, Wassmann S, Hilgers S, et al: Rapid effects on vascular function after initiation and withdrawal of atorvastatin in healthy, normocholesterolemic men. Am J Cardiol 88:1306-1307, 2001.[CrossRef][Web of Science][Medline] [Order article via Infotrieve]
• John S, Delles C, Jacobi J, et al: Rapid improvement of nitric oxide bioavailability after lipid-lowering therapy with cerivastatin within two weeks. J Am Coll Cardiol 37:1351-1358, 2001.[Abstract/Free Full Text]
• Plenge JK, Hernandez TL, Weil KM, et al: Simvastatin lowers C-reactive protein within 14 days: An effect independent of low-density lipoprotein cholesterol reduction. Circulation 106:1447-1452, 2002.[Abstract/Free Full Text]
• Wassmann S, Faul A, Hennen B, et al: Rapid effect of 3-hydroxy-3-methylglutaryl coenzyme A reductase inhibition on coronary endothelial function. Circ Res 93:e98-e103, 2003.[Abstract/Free Full Text]
• Tamai O, Matsuoka H, Itabe H, et al: Single LDL-aphaeresis improves endothelium-dependent vasodilation in hypercholesterolemic humans. Circulation 95:76-82, 1997.[Abstract/Free Full Text]
• Mellwig KP, Baller D, Gleichmann U, et al: Improvement of coronary vasodilation capacity through single LDL aphaeresis. Atherosclerosis 139:173-178, 1998.[CrossRef][Web of Science][Medline] [Order article via Infotrieve]
• Thome SA, Abbot SE, Winyard PG, et al: Extent of oxidative modification of low density lipoprotein determines the degree of cytotoxicity to human coronary artery cells. Heart 75:11-16, 1996.[Abstract/Free Full Text]
• Chen LY, Nichols WW, Hendricks J, et al: Myocardial neutrophil infiltration, lipid peroxidation, and antioxidant activity after coronary artery thrombosis and thrombolysis. Am Heart J 129:211-218, 1995.[CrossRef][Web of Science][Medline] [Order article via Infotrieve]
• Yamamoto A, Hoshi K, Ichihara K: Fluvastatin, an inhibitor of 3-hydroxy-3-methylglutaryl-CoA reductase, scavenges free radicals and inhibits lipid peroxidation in rat liver microsomes. Eur J Pharmacol 361: 143-149, 1998.[CrossRef][Web of Science][Medline] [Order article via Infotrieve]
• Pritchard KA, Groszek L, Smalley DM, et al: Native low-density lipoprotein increases endothelial cell nitric oxide synthase generation of superoxide anion. Circ Res 77:510-518, 1995.[Abstract/Free Full Text]
• Murphy RT, Foley JB, Mulvihill N, et al: Impact of preexisting statin use on adhesion molecule expression in patients presenting with acute coronary syndromes. Am J Cardiol 87:446-448, 2001.[CrossRef][Web of Science][Medline] [Order article via Infotrieve]
• Detmar M, Tenorio S, Hettmannsperger U, et al: Cytokine regulation of proliferation and ICAM-1 expression of human dermal microvascular endothelial cells in vitro. J Invest Dermatol 98:147-153, 1992.[CrossRef][Web of Science][Medline] [Order article via Infotrieve]
• Watson C, Whittaker S, Smith N, et al: IL-6 acts on endothelial cells to preferentially increase their adherence for lymphocytes. Clin Exp Immunol 105:112-119, 1996.[CrossRef][Web of Science][Medline] [Order article via Infotrieve]
• Schmidt AM, Hori O, Chen JX, et al: Advanced glycation end-products interacting with their endothelial receptor induce expression of vascular cell adhesion molecule-1 (VCAM-1) in cultured human endothelial cells and in mice: A potential mechanism for the accelerated vasculopathy of diabetes. J Clin Invest 96:1395-1403, 1995.[Web of Science][Medline] [Order article via Infotrieve]
• Yamashita H, Shimada K, Seki E, et al: Concentrations of interleukins, interferon and C-reactive protein in stable and unstable angina pectoris. Am J Cardiol 91:133-166, 2003.[CrossRef][Web of Science][Medline] [Order article via Infotrieve]
• Buffon A, Biasucci LM, Liuzzo G, et al: Widespread coronary inflammation in unstable angina. N Engl J Med 347:5-12, 2002.[Abstract/Free Full Text]
• Foody JM, Nissen SE: Effectiveness of statins in acute coronary syndromes. Am J Cardiol 88:31F-35F, 2001.[Web of Science][Medline] [Order article via Infotrieve]
• Weissberg P: Mechanisms modifying atherosclerotic disease—from lipids to vascular biology. Atherosclerosis 147(suppl 1):S3-S10, 1999.
• Hojo Y, Ikeda U, Katsuki T, et al: Interleukin 6 expression in coronary circulation after coronary angioplasty as a risk factor for restenosis. Heart 84:83-87, 2004.
• Davignon J: Beneficial cardiovascular pleiotropic effects of statins. Circulation 109(23 suppl 1):III39-III43, 2004.
• Fehr T, Kahlert C, Fierz W, et al: Statin-induced immunomodulatory effects on human T cells in vivo. Atherosclerosis 175:83-90, 2004.[CrossRef][Web of Science][Medline] [Order article via Infotrieve]

Angiology, Vol. 57, No. 2, 211-218 (2006)
DOI: 10.1177/000331970605700212


CiteULike    Complore    Connotea    Del.icio.us    Digg    Reddit    Technorati    Twitter    What's this?

This article has been cited by other articles:

				M Kohler, L Ayers, J C T Pepperell, K L Packwood, B Ferry, N Crosthwaite, S Craig, M M Siccoli, R J O Davies, and J R Stradling Effects of continuous positive airway pressure on systemic inflammation in patients with moderate to severe obstructive sleep apnoea: a randomised controlled trial Thorax, January 1, 2009; 64(1): 67 - 73. [Abstract] [Full Text] [PDF]

				R. LoPresti, A. Catania, T. D'Amico, M. Montana, M. Caruso, and G. Caimi Oxidative Stress in Young Subjects With Acute Myocardial Infarction: Evaluation at the Initial Stage and After 12 Months Clinical and Applied Thrombosis/Hemostasis, October 1, 2008; 14(4): 421 - 427. [Abstract] [PDF]

				Y. Ye, Y. Lin, J. R. Perez-Polo, B. F. Uretsky, Z. Ye, B. C. Tieu, and Y. Birnbaum Phosphorylation of 5-Lipoxygenase at Ser523 by Protein Kinase A Determines Whether Pioglitazone and Atorvastatin Induce Proinflammatory Leukotriene B4 or Anti-Inflammatory 15-Epi-Lipoxin A4 Production J. Immunol., September 1, 2008; 181(5): 3515 - 3523. [Abstract] [Full Text] [PDF]

				M. V. Poulakou, K. I. Paraskevas, I. S. Vlachos, S.-A. P. Karabina, M. R. Wilson, D. C. Iliopoulos, S. I. Tsitsilonis, D. P. Mikhailidis, and D. N. Perrea Effect of Statins on Serum Apolipoprotein J and Paraoxonase-1 Levels in Patients With Ischemic Heart Disease Undergoing Coronary Angiography Angiology, May 1, 2008; 59(2): 137 - 144. [Abstract] [PDF]

				S F E Praet, R A M Jonkers, G Schep, C D A Stehouwer, H Kuipers, H A Keizer, and L J van Loon Long-standing, insulin-treated type 2 diabetes patients with complications respond well to short-term resistance and interval exercise training Eur. J. Endocrinol., February 1, 2008; 158(2): 163 - 172. [Abstract] [Full Text] [PDF]

This Article Abstract Free Full Text (Free PDF) Free Alert me when this article is cited Alert me if a correction is posted Citation Map Services Email this article to a friend Similar articles in this journal Similar articles in Web of Science Similar articles in PubMed Alert me to new issues of the journal Add to Saved Citations Download to citation manager Request Permissions Request Reprints Add to My Marked Citations Citing Articles Citing Articles via HighWire Citing Articles via Web of Science (11) Citing Articles via Google Scholar Citing Articles via Scopus Google Scholar Articles by Marketou, M. E. Articles by Vardas, P. E. Search for Related Content PubMed PubMed Citation Articles by Marketou, M. E. Articles by Vardas, P. E. Social Bookmarking                         What's this?